To all:
QUIDEL Board Elects Andre de Bruin To Its Board Of Directors And Has Appointed Him Vice Chairman
SAN DIEGO, June 25 /PRNewswire/ -- QUIDEL Corporation (Nasdaq:QDEL) today announced that Mr. Andre de Bruin has been
elected to its Board of Directors and appointed Vice Chairman.
Mr. de Bruin presently serves as the Chairman, President and Chief Executive Officer of Somatogen, Inc. Somatogen, Inc. is a
biopharmaceutical company engaged in the research, clinical development and commercialization of genetically engineered
recombinant human hemoglobin-based products. Their lead compound, Optro(TM), is currently in Phase II clinical field trials.
Prior to joining Somatogen, Mr. de Bruin was Chairman, President and Chief Executive Officer of Boehringer Mannheim Corporation,
a private, global health care corporation with sales exceeding $3 billion. He held that position since 1989. Mr. de Bruin serves on the
Board of Directors of Diametrics Medical, Inc., a public company that manufactures and markets proprietary critical care blood and
tissue analysis systems, and Metobolex, Inc., a privately held company founded to develop therapeutics for diabetes and related
metabolic diseases. He has been involved in the global healthcare industry for more than 25 years in pharmaceuticals, devices and
diagnostics.
In commenting on Mr. de Bruin's election to the QUIDEL Board of Directors, Steven T. Frankel, President and Chief Executive
Officer of QUIDEL said, ``We are pleased to have Andre join the Board. His many years of experience with Miles/Bayer and
Boehringer Mannheim in all aspects of the diagnostic business will be very helpful to QUIDEL as we move into our next level of
growth.
QUIDEL Corporation discovers, develops, manufacturers, and markets rapid immunodiagnostic products for point-of-care detection
of human medical conditions and illnesses. These products provide simple, accurate and cost- effective diagnoses for acute and
chronic conditions in the areas of reproductive and women's health, infectious diseases, allergies and autoimmune disorders.
QUIDEL's products are sold to professionals in the physician's office and clinical laboratory, and to consumers through retail drug
stores. For more information, visit the company's web site at quidel.com. |
